MedTrace Logo

Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders

NCT01626989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2019-04-25

Study results available
· View outcomes & findings →

Summary

Comparing two BiPAP autoSV devices in participants with complex sleep apnea and determining if the new device will treat those participants no worse than when compared to its predecessor device.

Conditions

  • Sleep Disordered Breathing
  • Sleep Apnea, Central

Interventions

DEVICE

BiPAP auto Advanced

Auto Servo Ventilation Device

DEVICE

BiPAP auto SV4

Auto Servo Ventilation Device

Sponsors & Collaborators

  • Philips Respironics

    lead INDUSTRY

Principal Investigators

  • Shahrokh Javaheri, MD · Sleepcare Diagnostics

  • Paul Wylie, MD · Arkansas Center for Sleep Medicine

  • Mark Goetting, MD · Sleep Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01626989 on ClinicalTrials.gov